Global cooperation revealed a landslide, not a glacial collapse, likely initiated the cascade of events

Researchers at Cincinnati Children’s have identified a potential new way to relieve chronic pain linked to neurofibromatosis type 1 (NF1), a genetic condition best known for causing tumors to grow along nerves.

Researchers at Cincinnati Children’s found in mice that blocking excess GDNF production in Schwann cells may reduce chronic pain linked to neurofibromatosis type 1, even before tumors appear.

The force-activated ion channels underlie the senses of touch and proprioception. Now scientists are using them as a tool to explore molecular mechanisms at work in internal organs…

Cincinnati Children’s is accepting applications for its Summer Undergraduate Research Fellowship Program for students interested in biomedical science.

The atlas also offers up molecular and cellular targets for new pain therapies.

Phosphorylation of hundreds of protein extracellular domains is mediated by two kinase families but the functional role of these kinases is underexplored. We find that the presynaptic release of the t...

YouTube video by Steve Lawson

The Children's Tumor Foundation's mission is to drive research, expand knowledge, and advance care for the NF community.

YouTube video by Association of American Universities

The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.